title: Therapeutic options in atrial flutter and fibrillation.
abstract: Newer antiarrhythmic agents can control atrial flutter and fibrillation in many patients, although individual episodes may require cardioversion. Catheter ablation is often curative for refractory flutter. Ablation of atrial fibrillation is more difficult, because of its different mechanism. Surgical and catheter-based ablation procedures have been pioneered for fibrillation but remain experimental.
authors.affiliation: Department of Medicine, University of Chicago Pritzker School of Medicine, USA.
authors.forename: D J
authors.initials: DJ
authors.lastname: Wilber
authors.forename: R M
authors.initials: RM
authors.lastname: Gunnar
mesh_terms: D000368:Aged; D000465:Algorithms; D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use*; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000008:administration & dosage; D000959:Antihypertensive Agents / Q000008:administration & dosage; D001241:Aspirin / Q000008:administration & dosage; D001281:Atrial Fibrillation / Q000175:diagnosis / Q000601:surgery / Q000628:therapy*; D001282:Atrial Flutter / Q000175:diagnosis / Q000601:surgery / Q000628:therapy*; D017115:Catheter Ablation; D003937:Diagnosis, Differential; D004110:Diltiazem / Q000008:administration & dosage; D004554:Electric Countershock; D004562:Electrocardiography; D006801:Humans; D008297:Male; D012008:Recurrence
chemical_list: D000889:Anti-Arrhythmia Agents; D000894:Anti-Inflammatory Agents, Non-Steroidal; D000959:Antihypertensive Agents; D004110:Diltiazem; D001241:Aspirin